Moneycontrol PRO
Open App
you are here: HomeNewsBusiness

Companies may resume hiring activity by January 2021: Report

Campus hiring is expected to remain subdued, as 27 percent of companies stated they had no plans to resume the activity, while another 39 percent said they are unsure

July 09, 2020 / 01:06 PM IST
Representative Image

Representative Image

Companies have indicated that hiring across the board, with the exception of campus recruitments, will resume by January 2021, a report by Career Net Consulting found.

In fact, 43 percent of companies that halted hiring due to the coronavirus pandemic said that they have already begun "selectively filling" positions that would become active in six months, The Economic Times reported.

"This seems to be a 15-16 month cycle and momentum should touch pre-COVID-19 levels by April 2020, at a lower base due to downsizing over the last six months," Anshuman Das, co-founder of Career Net told the paper.

Follow our LIVE updates on the coronavirus pandemic here

Close to 34 percent of Human Resource (HR) and talent acquisition team heads said they would hire this year. However, campus hiring is expected to remain subdued as 27 percent of companies stated they had no plans to resume the activity, while another 39 percent said they are unsure.


COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

"Campus hiring for the year is already deferred and we expect this to be more phased out once organisations re-open," Das added.

In terms of whether employee strength would return to pre-COVID-19 levels, the report was inconclusive as companies – particularly startups, said they would have to consider "recalibrated demand, economics and external fundraising environment" before deciding.

Das pointed out that the slowdown is a “new phenomenon” for relatively young startups when compared to better established ITeS companies. Case in point: Three out of four ITeS firms are honouring offer letters, the report noted.

Follow our full COVID-19 coverage here
Moneycontrol News
first published: Jul 9, 2020 01:06 pm
ISO 27001 - BSI Assurance Mark